Cell growth effects of Epstein—Barr virus leader protein

References

1. Allan G. J., Rowe D. T. 1989; Size and stability of the Epstein- Barr virus major internal repeat (IR-1) in Burkitt’s lymphoma and lymphoblastoid cell lines. Virology 173:489–498
   [Google Scholar]
2. Bodescot M., Chambraud B., Perricaudet M., Farrell P. J. 1984; Spliced RNA from the IR1-U2 region of Epstein-Barr virus: presence of an open reading frame for a repetitive polypeptide. EMBO Journal 3:1913–1917
   [Google Scholar]
3. Buschle M., Brenner M. K., Chen I. S. Y., Drexler H. G., Gignac S. M., Rooney C. M. 1990; Transfection and gene expression in normal and malignant primary B lymphocytes. Journal of Immunological Methods 133:77–86
   [Google Scholar]
4. Cohen J. I., Wang F., Mannick J., Kieff E. 1989; Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proceedings of the National Academy of Sciences, U,. S,. A 86:9558–9562
   [Google Scholar]
5. Delius H., Bornkamm G. W. 1978; Heterogeneity of Epstein- Barr virus. III. Comparison of a transforming and non-transforming virus by partial denaturation mapping of their DNAs. Journal of Virology 27:81–89
   [Google Scholar]
6. Dillner J., Kallin B., Alexander H., Ernberg I., Uno M., Uno Y., Klein G., Lerner R. A. 1986; An Epstein-Barr virus determined nuclear antigen (EBNA-5) is partly encoded by the transformation associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cells lines. Proceedings of the National Academy of Sciences, U,. S,. A. 83:6641–6645
   [Google Scholar]
7. Fields B. N., Knife D. M. (editors) 1990 Virology 2nd edn., New York: Raven Press;
   [Google Scholar]
8. Finke J., Rowe M., Kallin B., Ernberg I., Rosen A., Dillner J., Klein G. 1987; Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt’s lymphoma and lymphoblastoid cell lines. Journal of Virology 61:3870–3878
   [Google Scholar]
9. Hammerschmidt W., Sugden B. 1989; Genetic analysis of immortalising functions of Epstein-Barr virus in human B lymphocytes. Nature, London 340:393–397
   [Google Scholar]
10. Jiang W. Q., Wendelhansen V., Lundkvist A., Ringertz N., Klein G., Rosen A. 1991; Intranuclear distribution of Epstein-Barr virus encoded nuclear antigens EBNA-1, EBNA-2, EBNA-3 and EBNA-5. Journal of Cell Science 99:497–502
    [Google Scholar]
11. Jones M. D., Foster L., Sheedy T., Griffin B. E. 1984; The EB virus genome in Daudi Burkitt’s lymphoma cells has a deletion similar to that observed in a non-transforming strain, P3HR-1, of the virus. EMBO Journal 3:813–821
    [Google Scholar]
12. Mannick J. B., Cohen J. I., Birkenbach M., Marchini A., Kieff E. 1991; The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. Journal of Virology 65:6826–6837
    [Google Scholar]
13. Menezes J., Leibold W., Klein G. 1975; Biological differences between different Epstein-Barr virus (EBV) strains with regard to lymphocyte transforming ability. Experimental Cell Research 92:478–484
    [Google Scholar]
14. Miller G., Robinson J., Heston L., Lipman M. 1974; Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection and interference. Proceedings of the National Academy of Sciences, U,. S,. A 71:4006–4010
    [Google Scholar]
15. Petti L., Sample J., Kieff E. 1990; Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins. Virology 176:563–574
    [Google Scholar]
16. Raab-Traub N., Pritchett R., Kieff E. 1978; DNA of Epstein-Barr virus III: identification of restriction enzyme fragments that contain DNA sequences which differ among strains of Epstein-Barr virus. Journal of Virology 27:388–398
    [Google Scholar]
17. Rabson M., Gradoville L., Heston L., Miller G. 1982; Nonimmortalizing P3HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye. Journal of Virology 44:834–844
    [Google Scholar]
18. Rowe D. T., Rowe M., Evan G. I., Wallace L. E., Farrell P. J., Rickinson A. B. 1986; Restricted expression of EBV latent genes and T lymphocyte detected membrane antigen in Burkitt’s lymphoma cells. EMBO Journal 5:2599–2607
    [Google Scholar]
19. Rowe D. T., Farrell P. J., Miller G. 1987; Novel Epstein-Barr virus nuclear antigens recognised by human sera in latently infected lymphocytes. Virology 156:153–162
    [Google Scholar]
20. Sample J., Hummel M., Braun D., Birkenbach M., Kieff E. 1986; Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. Proceedings of the National Academy of Sciences, U,. S,. A. 83:5096–5100
    [Google Scholar]
21. Sauter N., Boos H., Hirsch F., Muller-Lantzsch N. 1988; Characterization of a latent protein encoded by the large internal repeats and the Bam HI Y fragment of the Epstein-Barr virus (EBV) genome. Virology 166:586–590
    [Google Scholar]
22. Speck S. H., Pfitzner A., Strominger J. L. 1986; An Epstein-Barr virus transcript from a latently infected, growth-transformed B-cell line encodes a highly repetitive polypeptide. Proceedings of the National Academy of Sciences, U,. S,. A 839298–9302
    [Google Scholar]